Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Carboplatin

Drug name(s)

Paraplatin® Carboplatin

Approved for

  • Other Blood Cancers

Cisplatin

Drug name(s)

Platinol®-AQ Cisplatin

Approved for

  • Other Blood Cancers

Dasatinib

Drug name(s)

Sprycel® Phyrago® Dasatinib

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML)

Dexamethasone

Drug name(s)

Prednisone Decadron® Medrol® Methylprednisolone Dexamethasone

Approved for

  • Other Blood Cancers

Epoetin alfa

Drug name(s)

Epogen® Procrit® EPO Epoetin alfa Epoetin alfa-epbx* Retacrit™ *

Approved for

  • Other Blood Cancers

Mercaptopurine

Drug name(s)

Purinethol® 6-MP Purixan® Mercaptopurine

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Mogamulizumab

Drug name(s)

Poteligeo® Mogamulizumab

Approved for

  • Other Blood Cancers

Pacritinib

Drug name(s)

Vonjo™ Pacritinib

Approved for

  • Primary Myelofibrosis
  • Polycythemia Vera
  • Other Blood Cancers

Palifermin

Drug name(s)

Kepivance® Palifermin

Approved for

  • Other Blood Cancers

Pamidronate

Drug name(s)

Aredia® Pamidronate

Approved for

  • Myeloma
  • Other Blood Cancers

Panobinostat

Drug name(s)

Farydak® Panobinostat

Approved for

  • Myeloma

Pegaspargase

Drug name(s)

Oncaspar® PEG-L-asparaginase Pegaspargase

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Pegfilgrastim

Drug name(s)

Neulasta® Pegfilgrastim G-CSF Fulphila™ * Pegfilgrastim-jmdb* Udenyca™ * Pegfilgrastim-cbqv* Ziextenzo™ * Pegfilgrastim-bmez * Nyvepria Pegfilgrastim-apgf* Fylnetra* Pegfilgrastim-pbbk* Stimufend®* Pegfilgrastim-fpgk*

Approved for

  • Other Blood Cancers

Pembrolizumab

Drug name(s)

Keytruda® Pembrolizumab

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Primary Mediastinal (Thymic) Large B-cell Lymphoma (PMBCL)
  • Other Blood Cancers

Pentostatin

Drug name(s)

Nipent® Pentostatin

Approved for

  • Leukemia
  • Hairy Cell Leukemia (HCL)
  • Essential Thrombocythemia
  • Other Blood Cancers

Pirtobrutinib

Drug name(s)

Pirtobrutinib Jaypirca®

Approved for

  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma
  • Mantle Cell Lymphoma (MCL) 

Pivekimab sunirine-pvzy

Drug name(s)

Pivekimab sunirine-pvzy Decnupaz™

Approved for

  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Plerixafor

Drug name(s)

Mozobil® Plerixafor

Approved for

  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Myeloma

Polatuzumab vedotin-piiq

Drug name(s)

Polivy® Polatuzumab vedotin-piiq

Approved for

  • Lymphoma
  • Diffuse Large B-cell Lymphoma (DLBCL) 
  • Other Blood Cancers

Pomalidomide

Drug name(s)

Pomalyst® Pomalidomide

Approved for

  • Myeloma

Ponatinib

Drug name(s)

Iclusig® Ponatinib

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML)

Pralatrexate

Drug name(s)

Folotyn® Pralatrexate

Approved for

  • Large B-Cell Lymphoma (LBCL)
  • Lymphoma
  • Adult T-cell Leukemia/Lymphoma
  • Other Blood Cancers

Procarbazine

Drug name(s)

Matulane® Procarbazine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.